Literature DB >> 2140597

Mouse vimentin: structural relationship to fos, jun, CREB and tpr.

Y Capetanaki1, I Kuisk, K Rothblum, S Starnes.   

Abstract

We have isolated and characterized mouse cDNA clones representing the entire coding region of vimentin. RNA blot analysis of different stages during development has revealed differential control in the expression of vimentin mRNA in the different tissues studied. The nucleotide sequence extends 1800 base pairs and contains the 466 amino acid mouse vimentin polypeptide chain, flanked by 90 base pairs 5' and 312 base pairs 3' untranslated region. Conformational analysis of the deduced amino acid sequence was used to localize the three known structural domains: a non-alpha-helical N-terminal head of 81 residues, a rod-like domain of 330 residues arising from three alpha-helices, and a non-alpha-helical C-terminal domain of 55 residues. Amino acid sequence comparisons with other species revealed high sequence conservation of mouse vimentin to hamster (98.7%), human (96%), and chicken (88%) protein. Computer sequence analysis also revealed domains of significant homology between different alpha helical regions of vimentin and the DNA binding-leucine zipper domain of several proto-oncogenes and transcription regulators. Specifically, 50-70% structural similarity was observed between the basic domain of the DNA binding region of the nuclear proto-oncogene products c-fos and its related antigen fra-1, c-jun and the cAMP-responsive DNA binding protein CREB, with part of the N-terminal half region of helix 1b of vimentin. When the leucine zipper domains of all these proteins were compared to vimentin, at least two different regions of similarity in the vimentin molecule were found reaching up to 53% for jun, 60% for fos, and 76% for CREB. Further analysis revealed several domains of significant similarity (50%) between all alpha-helices of the rod domain of vimentin and the N-terminal (approximately 210 residues) activation domain tpr of the oncogenic raf.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140597

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Desmin cytoskeleton in healthy and failing heart.

Authors:  Y Capetanaki
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 2.  Mouse map of paralogous genes.

Authors:  J H Nadeau; M Kosowsky
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

3.  The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions.

Authors:  N R Soman; P Correa; B A Ruiz; G N Wogan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.

Authors:  T J Liang; A E Reid; R Xavier; R D Cardiff; T C Wang
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours.

Authors:  H Baribault; M Wilson-Heiner; W Muller; J Penner; N Bakhiet
Journal:  Transgenic Res       Date:  1997-11       Impact factor: 2.788

6.  Presence of the intermediate filaments cytokeratins and vimentin in the rat corpus luteum during luteal life-span.

Authors:  I Nilsson; M O Mattsson; G Selstam
Journal:  Histochem Cell Biol       Date:  1995-03       Impact factor: 4.304

7.  Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.

Authors:  G A Rodrigues; M Park
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

8.  RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network.

Authors:  W C Sin; X Q Chen; T Leung; L Lim
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

Review 9.  Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin.

Authors:  Elly M Hol; Yassemi Capetanaki
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

10.  Vimentin inhibits ATF4-mediated osteocalcin transcription and osteoblast differentiation.

Authors:  Na Lian; Weiguang Wang; Lingzhen Li; Florent Elefteriou; Xiangli Yang
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.